# Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction

> **NCT05446493** · PHASE4 · COMPLETED · sponsor: **Aswan University** · enrollment: 60 (actual)

## Conditions studied

- Erectile Dysfunction
- Erectile Dysfunction With Diabetes Mellitus

## Interventions

- **DRUG:** Tadalafil 5mg

## Key facts

- **NCT ID:** NCT05446493
- **Lead sponsor:** Aswan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2021-03-15
- **Final completion:** 2022-01-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05446493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05446493, "Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05446493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*